| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.086 | 0.002 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.004 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.33 | 0.004 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.18 | 0.005 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.006 |